Medtronic's earnings beat estimates as sales of diabetes and heart devices rise
Medtronic ’s stock rose about 2 percent in afternoon trading after the company reported earnings that beat analyst expectations. The medical-device giant’s adjusted profit in the fourth quarter reached $1.44 per share, 5 cents higher than Wall Street estimates. The company’s revenue climbed to $8.14 bi llion for the fourth quarter, up about 3 percent compared to the year-ago period. Medtronic reported revenue growth across most of its business lines, with sales in its diabetes business leaping… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 24, 2018 Category: Pharmaceuticals Authors: Katharine Grayson Source Type: news

Medtronic tops estimates with fiscal Q4, 2018 results
Medtronic (NYSE:MDT) today reported fiscal fourth-quarter and 2018 numbers that beat Wall Street’s best guesses for sales and earnings. The Fridley, Minn.-based medical device giant posted profits of $1.46 billion, or $1.07 per share, on sales of $8.14 billion for the three months ended April 27, representing bottom-line growth of 25.5% on sales growth of 2.9% compared with the same period last year. Adjusted to exclude one-time items, earnings per share were $1.44, a full nickel ahead of The Street, where analysts were looking for sales of $7.74 billion. Full-year profits were $3.10 billion, or $2.27 per share, on s...
Source: Mass Device - May 24, 2018 Category: Medical Devices Authors: Brad Perriello Tags: MassDevice Earnings Roundup Wall Street Beat Medtronic Source Type: news

McKesson Reports Fiscal 2018 Fourth-Quarter and Full-Year Results
Revenues of $51.6 billion for the fourth quarter and $208.4 billion for the full year.Fourth-quarter GAAP loss per diluted share from continuing operations of $(5.58) and full-year GAAP earnings per diluted share from continuing operations of $0.30.Fourth-quarter Adjusted Earnings per diluted share ... (Source: McKesson News)
Source: McKesson News - May 24, 2018 Category: Information Technology Source Type: news

Philips, AHA, UPMC launch $30m heart-focused venture fund
Royal Philips (NYSE:PHG) said late last week it is joining with the American Heart Association and UPMC to launch a $30 million heart-focused collaborative venture capital fund. The newly formed Cardeation Capital fund will support innovation in products for treating heart disease and stroke care. The fund will be managed by Aphelion Capital, with each major player contributing $10 million, Amsterdam-based Philips said. Cardeation Capital will look to invest in companies trying to treat cardiovascular diseases and stroke and their risk factors, including diabetes, according to Philips. “At Philips our goal is to...
Source: Mass Device - May 21, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiovascular Wall Street Beat American Heart Assn. royalphilips UPMC Source Type: news

AstraZeneca sales hit by generic competitors to Crestor statin
Pharma group’s core operating profit falls 47% in first quarter (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - May 18, 2018 Category: Pharmaceuticals Source Type: news

Hawaii Medical Service Association reports $17M net loss for Q1 2018
The Hawaii Medical Service Association  reported a net loss of $17.6 million for the first quarter of 2018, citing taxes and fees from the Affordable Care Act as the reason for the loss. Hawaii’s largest health insurer said it recorded $67.9 million in ACA taxes and fees in the first three months of the year. HMSA collected $876.3 million in premium revenue for the first quarter, compared to $848 million in the first quarter of 2017. The company paid $757.6 million for its members’ medical… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - May 16, 2018 Category: Health Management Authors: Anna Hrushka Source Type: news

Hawaii Medical Service Association reports $17M net loss for Q1 2018
The Hawaii Medical Service Association  reported a net loss of $17.6 million for the first quarter of 2018, citing taxes and fees from the Affordable Care Act as the reason for the loss. Hawaii’s largest health insurer said it recorded $67.9 million in ACA taxes and fees in the first three months of the year. HMSA collected $876.3 million in premium revenue for the first quarter, compared to $848 million in the first quarter of 2017. The company paid $757.6 million for its members’ medical… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 16, 2018 Category: Biotechnology Authors: Anna Hrushka Source Type: news

K2M launches 3D-printed Mojave PL interbody fusion system
K2M (NSDQ:KTWO) said today it launched the Mojave PL 3D expandable interbody system featuring its lamellar 3D titanium technology. The Leesburg, Va.-based company features a porous structure and rough surfaces intended to support bony integration throughout the endplates of the system. K2M said the device won FDA 510(k) clearance last June. “Advancements in expandable interbody technology are giving new hope to surgeons who treat sagittal imbalance, which often causes patients to live in chronic pain and discomfort. The Mojave PL 3D expandable interbody system is a first-of-its-kind solution. Designed with ...
Source: Mass Device - May 16, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Spinal K2M Source Type: news

Neovasc continues pursuit of 1-for-100 reverse stock split
Neovasc (NSDQ:NVCN) said today that it will proceed with plans for a reverse stock split with a ratio of up to 1-for-100, with board members and management urging shareholders to vote for the proposal at an upcoming special meeting. The Vancouver-based company will vote on the proposition on June 4, according to a recently posted SEC filing, as the company looks to regain compliance with the NASDAQ minimum bid requirement. Neovasc warned that failure to approve the move could lead to a reduction in the liquidity in trading of its shares, difficulty raising capital from US-based institutional funds and an increase in i...
Source: Mass Device - May 16, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Wall Street Beat Neovasc Inc. Source Type: news

State's biggest health insurance firms blame Obamacare tax for Q1 losses
The state ’s largest insurers suffered deep losses in the first quarter of 2018, blaming the red ink on a newly-resumed tax of the Affordable Care Act. Blue Cross Blue Shield of Massachusetts, the state’s largest insurer with 2.8 million members, reported a $97.2 million operating loss in the first quar ter, compared to a $10.6 million operating gain in the same period last year. Harvard Pilgrim Health Care, which has the second largest membership at 1.3 million members, reported a $9.4 million… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 16, 2018 Category: American Health Authors: Jessica Bartlett Source Type: news

Avinger shares rise on shrinking losses in Q1 earnings
Shares in Avinger (NSDQ:AVGR) rose today after the medical device maker posted first quarter earnings that saw losses shrinking, despite missing consensus on Wall Street. The Redwood City, Calif.-based company posted losses of $10.7 million, or $5.37 per share, on sales of $1.8 million for the three months ended March 31, seeing losses shrink 30.3% while sales shrunk 48.2% compared with the same period during the previous year. Losses-per-share were well ahead of the 84¢ consensus on Wall Street, where analysts expected too see sales of $2 million. “We achieved several major successes during the first quart...
Source: Mass Device - May 15, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat Avinger Source Type: news

Update: Avinger shares rise on Q1 earnings
Updated to reflect corrected financial data from Avinger. Shares in Avinger (NSDQ:AVGR) rose today after the medical device maker posted first quarter earnings that saw losses shrinking, despite missing consensus on Wall Street. The Redwood City, Calif.-based company posted losses of $15.9 million, or $7.99 per share, on sales of $1.8 million for the three months ended March 31, seeing losses grow 3.7% while sales shrunk 48.2% compared with the same period during the previous year. Losses-per-share were well ahead of the 84¢ consensus on Wall Street, where analysts expected too see sales of $2 million. “We ...
Source: Mass Device - May 15, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat Avinger Source Type: news

Bovie Medical shares rise on Q1 sales Beat, closed enrollment of cosmetic J-Plasma IDE study
Shares in Bovie Medical (NYSE:BVX) rose today after the medical device maker beat sales expectations on Wall Street with its first quarter earnings release and announced that it closed enrollment of an FDA investigational device exemption study of its J-Plasma tech seeking a new cosmetic indication. The Clearwater, Fla.-based company posted losses of $935,000, or 3¢ per share, on sales of $9.9 million for the three months ended March 31, seeing losses grow 44.5% while sales grew 18.2% compared with the same period during the previous year. Losses-per-share were just below the 2¢ consensus on Wall Street, whe...
Source: Mass Device - May 15, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Clinical Trials Cosmetic/Aesthetic MassDevice Earnings Roundup Wall Street Beat Bovie Medical Corp. Source Type: news

Hill-Rom opens new Central N.Y.-based Welch Allyn facility
Hill-Rom Holdings (NYSE:HRC) last Friday opened its recently built Skaneateles Falls, N.Y. location, which will serve as expansion space for its Welch Allyn division. The newly opened 100,000-square-foot Central New York facility will allow the Batesville, Ind.-based company to add a number of new positions, including R&D and engineering roles, as well as allowing for expansion of the Front Line Care biz and its largest component, Welch Allyn. “The contributions of our Welch Allyn team enable Hill-Rom to help people get better care inside and outside the hospital, and we are energized about our expansio...
Source: Mass Device - May 15, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Hill-Rom Holdings Inc. Source Type: news

OrthoPediatrics announces Femur pediatric nailing platform FDA nod, Q1 earnings
OrthoPediatrics this week announced it won FDA 510(k) clearance for its Femur pediatric nailing platform and released its first quarter earnings, beating sales consensus but missing on loss-per-share expectations on Wall Street. The Warsaw, Ind.-based company’s Femur system is designed to accompany two pediatric-specific nail offerings, and is an upgrade to an earlier version of the device. OrthoPediatrics said the clearance of the device is the “next step” in the evolution of its intramedullary nailing franchise. “Our team is excited about the pediatric nailing platform. We worked alongside pe...
Source: Mass Device - May 15, 2018 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Business/Financial News Food & Drug Administration (FDA) MassDevice Earnings Roundup Orthopedics Regulatory/Compliance Wall Street Beat OrthoPediatrics Corp. Source Type: news

Mazor Robotics shares rise on Street-beating Q1
Shares in Mazor Robotics (NSDQ:MZOR) rose today after the surgical robotic platform maker beat expectations on Wall Street with its first quarter 2018 earnings. The Caesarea, Israel-based company posted losses of $1.3 million, or 2¢ per share, on sales of $15.5 million for the three months ended March 31, seeing losses shrink 75.6% while sales grew 32.3% compared with the same period during the previous fiscal year. Losses per share were ahead of the 8¢ consensus on Wall Street, where analysts expected to see sales of $15.1 million for the quarter, which the company topped. “Our record first quarter re...
Source: Mass Device - May 14, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat mazorrobotics Source Type: news

The Joint Corp. reduces first quarter losses
Franchising company is reducing time it takes for clinics to become profitable. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 13, 2018 Category: American Health Authors: Angela Gonzales Source Type: news

The Joint Corp. reduces first quarter losses
Franchising company is reducing time it takes for clinics to become profitable. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 13, 2018 Category: Biotechnology Authors: Angela Gonzales Source Type: news

DJO Global posts shrinking losses, growing sales in Q1
DJO Global saw losses shrink and sales rise as a result of internal efforts to transform its business and reduce costs, according to its first quarter earnings release. The privately held, San Diego-based medical device maker posted losses of $17.6 million on sales of $292.6 million for the three months ended March 31, seeing losses shrink 56% while sales grew 1.5% compared with the same period during the previous year. DJO Global reported that its adjusted EBITDA increased 13.2% over the same year during the previous quarter, clocking in at $64.8 million. “After starting the quarter with slow revenue trends ref...
Source: Mass Device - May 11, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat DJO Global Source Type: news

Neovasc shares down on Q1 miss, plans 1-for-100 reverse split
Shares in Neovasc (NSDQ:NVCN) have fallen today after the medical device maker missed Wall Street expectations and posted growing losses in its first quarter earnings release, alongside plans for a 1-for-100 reverse split. The Vancouver-based company posted losses of $55.5 million, or 38¢ per share, on sales of $339,922 for the three months ended March 31, seeing losses grow nearly 600% while sales shrunk 77.1% compared with the same period during the previous year. Losses-per-share were significantly off from the 3¢ consensus on The Street, where analysts expected to see sales of $870,000, which the company...
Source: Mass Device - May 11, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat Neovasc Inc. Source Type: news

ViewRay shares dip despite Q1 earnings Beat
Shares in ViewRay (NSDQ:VRAY) fell today despite the medical device maker posting first quarter earnings that beat expectations on Wall Street. The Cleveland-based company posted losses of $7.5 million, or 11¢ per share, on sales of $26.2 million for the three months ended March 31, seeing losses shrink 73% while sales grew over 2000% compared with the same period during the previous year. Losses per share were ahead of the 19¢ consensus on Wall Street, where analysts expected to see sales of $12.1 million, which the company handily topped. “During the first quarter we continued to build momentum by ge...
Source: Mass Device - May 11, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat ViewRay Inc. Source Type: news

Senseonics Q1 misses on EPS
Shares in Senseonics (NYSE:SENS) have fallen slightly today after the continuous glucose monitoring-focused medtech company posted first quarter earnings that missed on earnings per share expectations but beat sales consensus on Wall Street. The Germantown, Md.-based company posted losses of $22.3 million, or 16¢ per share, on sales of $2.9 million for the three months ended March 31, seeing losses grow 70.4% while sales grew 432.7% compared with the same period during the previous year. Read the whole story on our sister site, Drug Delivery Business The post Senseonics Q1 misses on EPS appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - May 11, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat Senseonics Source Type: news

Myomo shares fall on Q1 miss
Shares in Myomo fell yesterday after the wearable medical robotics company missed expectations on Wall Street with its first quarter earnings. The Cambridge, Mass.-based company posted losses of $2.3 million, or 20¢ per share, on sales of $313,179 for the three months ended March 31, seeing losses grow 50.7% while sales grew 44.8% compared with the same period during the previous year. Losses per share were just behind the 20¢ consensus on Wall Street, where analysts expected to see sales of $570,000, which the company also missed. “Early in the year, with the growth capital raised in December 2017, we...
Source: Mass Device - May 11, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat Myomo Inc Source Type: news

Inovio Pharma shares fall on Q1 miss
Shares in Inovio Pharmaceuticals (NSDQ:INO) have fallen today after the biotech company missed expectations on Wall Street with its first quarter earnings results. The Plymouth Meeting, Penn.-based company posted losses of $32.4 million, or 36¢ per share, on sales of $1.5 million for the three months ended March 31, seeing losses grow 40.1% while sales shrunk 85.3% compared with the same period during the previous year. Read the whole story on our sister site, Drug Delivery Business The post Inovio Pharma shares fall on Q1 miss appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - May 10, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat Inovio Pharmaceuticals Source Type: news

Glaukos posts red ink in Q1 earnings
Shares in Glaukos (NYSE:GKOS) have fallen today after the ophthalmic medical tech company posted first quarter earnings that saw profits swing to losses, despite topping The Street’s expectations. The San Clemente, Calif.-based company posted losses of $2.7 million, or 8¢ per share, on sales of $40.1 million for the three months ended March 31, seeing an over 400% swing into red on the bottom-line while sales grew 11.8% compared with the same period during the previous year. Read the whole story on our sister site, Drug Delivery Business The post Glaukos posts red ink in Q1 earnings appeared first on MassDe...
Source: Mass Device - May 10, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Optical/Ophthalmic Wall Street Beat Glaukos Source Type: news

Integra LifeSciences prices $307m offering, extends BofA loan
Integra LifeSciences (NSDQ:IART) this week priced a public offering worth up to $307 million and announced it amended an existing credit facility with a bank group led by Bank of America. In its upcoming offering, the Plainsboro, N.J.-based company said it plans to float approximately 5.3 million shares of common stock at $58.50 per share. The offering also includes a 30-day underwriter’s option to purchase an additional 787,500 shares of common stock. The offering is expected to close on May 14, according to a press release. Proceeds from the offering are slated to help reduce borrowings through the compan...
Source: Mass Device - May 10, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News integralifesciences Source Type: news

Wright Medical ’ s Q1 bests estimates
Wright Medical (NSDQ:WMGI) yesterday posted first-quarter results that topped the consensus estimate on Wall Street and said it won a nearly $31 million dispute with an insurer over its recalled ProFemur hip implant. Memphis, Tenn.-based Wright slashed its losses by -56.5% to -$25.5 million, or -24¢ per share, on sales growth of 12.0% to $198.5 million for the three months ended April 1, compared with Q1 2017. Adjusted to exclude one-time items, earnings per share were -1¢, a full 6¢ ahead of The Street, where analysts were looking for revenues of $194.0 million. “We delivered strong results across the...
Source: Mass Device - May 10, 2018 Category: Medical Devices Authors: Brad Perriello Tags: MassDevice Earnings Roundup Orthopedics Wall Street Beat wrightmedical Source Type: news

Penumbra shares rise on Q1 beat, growing sales
Shares in Penumbra (NYSE:PEN) rose today after the medical device maker topped expectations on Wall Street with its first quarter 2018 earnings results. The Alameda, Calif.-based company posted profits of $5.5 million, or 15¢ per share, on sales of $102.7 million for the three months ended March 31, seeing a swing from the red on the bottom line while sales grew 40.3% compared with the same period during the previous year. Earnings per share were well ahead of the 2¢ loss-per-share expectations on Wall Street, where analysts expected to see sales of $91.7 million, which the company also topped. Penumbra lift...
Source: Mass Device - May 9, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat Penumbra Inc. Source Type: news

TransEnterix shares rise on Street-beating Q1
Shares in TransEnterix (NYSE:TRXC) rose today after the medical device maker beat expectations on Wall Street with its first quarter earnings results. The Research Triangle Park, N.C.-based company posted losses of $882,000, or 0¢ per share, on sales of $4.8 million for the three months ended March 31, seeing losses shrink 94.3¢ while sales grew 145% compared with the same period during the previous year. Adjusted to exclude one-time items, losses per share were just ahead of the 7¢ consensus on Wall Street, where analysts expected to see sales of $3.8 million, which the company handily topped. “W...
Source: Mass Device - May 9, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat TransEnterix Source Type: news

Corindus Vascular Robotics shares fall on Q1 sales miss
Shares in Corindus Vascular Robotics (OTC:CVRS) fell today after the robotic-surgery platform maker missed sales expectations on Wall Street with its first quarter 2018 earnings results. The Waltham, Mass.-based company posted losses of approximately $10.1 million, or 8¢ per share, on sales of $1.5 million for the three months ended March 31, seeing losses grow 1.7% while sales grew 91.1% compared with the same period during the previous year. Losses per share were slightly greater than the 5¢ consensus on Wall Street, where analysts were expecting to see sales of $3.7 million for the quarter, which the comp...
Source: Mass Device - May 9, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat Corindus Vascular Robotics Source Type: news

Kindred Healthcare reduces 1Q loss as company takeover continues
Kindred Healthcare Inc. posted a lower loss in the first quarter of the year compared to a year earlier as it continues to work through its acquisition by Louisville-based Humana Inc. and two private-equity firms. The Louisville-based post-acute and home care provider saw its revenue dip 1.7 percent for the first quarter to $1.51 billion from $1.54 billion. Kindred's net loss for the quarter was $1.71 million, a 70.3 percent reduction from a $5.75 million loss a year earlier. On a per-share basis,… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 9, 2018 Category: American Health Authors: Chris Larson Source Type: news

Mylan misses estimates on The Street with Q1 results
Shares in Mylan (NSDQ:MYL) rose slightly this morning after the pharmaceutical company reported its first-quarter financial results, missing analysts’ sales and earnings estimates. The company posted profits of $87.1 million, or 17¢ per share, on sales of $2.68 billion for the 3 months ended March 31, for bottom-line growth of 31% on sales loss of -1% compared with the same period last year. Get the full story at our sister site, Drug Delivery Business News. The post Mylan misses estimates on The Street with Q1 results appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - May 9, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: MassDevice Earnings Roundup Pharmaceuticals Wall Street Beat Mylan Source Type: news

CHF Solutions shares down on Q1 miss
Shares in CHF Solutions (NSDQ:CHFS) have fallen today after the heart-focused medical device maker missed expectations on Wall Street with its first quarter earnings results. The Eden Prairie, Minn.-based company posted losses of $4.4 million, or $1.08 per share, on sales of $1 million for the three months ended March 31, seeing losses grow 363% while sales grew by 15.1% compared with the same period during the previous year. CHF Solutions losses-per-share were far behind the Wall Street consensus of 56¢ per share, where analysts expected to see sales of $1.7 million, which the company also missed. “We bega...
Source: Mass Device - May 8, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat CHF Solutions Inc. Source Type: news

Henry Schein shares down despite Street-beating Q1
Shares in Henry Schein (NSDQ:HSIC) have fallen today despite the medical device maker beating expectations on Wall Street with its first quarter 2018 earnings release. The Melville, N.Y.-based company posted profits of $140.2 million, or 91¢ per share, on sales of $3.2 billion for the three months ended March 31, seeing the bottom-line shrink 0.4% while sales grew 10.2% compared with the same period during the previous year. Adjusted to exclude one-time items, earnings per share were 95¢, just ahead of the 92¢ consensus on Wall Street where analysts expected to see sales of $3.2 billion, which the compa...
Source: Mass Device - May 8, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat Henry Schein Inc. Source Type: news

Nevro dives on missed Q1 estimates
Share in Nevro Corp. (NYSE:NVRO) took a hit on Wall Street today as investors reacted to first-quarter sales and earnings numbers that missed the forecast. The Redwood City, Calif.-based neuromodulation company yesterday posted losses of -$17.5 million, or -59¢ per share, on sales of $87.6 million for the three months ended March 31, increasing its losses by 19.1% on sales growth of 28.0%. Analysts on The Street were looking for losses of -32¢ on sales of $89.5 million. “Reflecting on our first quarter, I’m confident in the fundamentals of our business and in our ability to achieve market leaders...
Source: Mass Device - May 8, 2018 Category: Medical Devices Authors: Brad Perriello Tags: MassDevice Earnings Roundup Neuromodulation/Neurostimulation Wall Street Beat nevro Source Type: news

Haemonetics swings to black for fiscal Q4, 2018
Haemonetics (NYSE:HAE) eked out a sales-and-earnings beat with its fiscal fourth-quarter and 2018 numbers today, posting swings to black ink for both periods. The Braintree, Mass.-based blood management company reported profits of $11.9 million, or 22¢ per share, on sales of $233.6 million for the three months ended March 31, compared with losses of -$51.1 million during the same period last year; sales grew 2.4% over fiscal Q4 2017. Adjusted to exclude one-time items, earnings per share were 43¢, a penny ahead of Wall Street, where analysts were looking for sales of $227.1 million. Full-year profits were $4...
Source: Mass Device - May 8, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Blood Management MassDevice Earnings Roundup Wall Street Beat Haemonetics Source Type: news

Cardinal Stumbles with Cordis, But Can Recover
When Cardinal Health acquired Johnson and Johnson’s Cordis unit for $1.94 billion in 2015, it seemed like an all-around good plan for all parties involved. The sale of Fremont, CA-based Cordis would give J&J the ability to focus on more profitable sections like pharmaceuticals. It would also give Cardinal Health the ability to stretch its wings into the medtech space. However things don’t always work out as planned. In its latest earnings call, Dublin, OH-based Cardinal Health said its sales increased about 5.7% to $33.63 billion in the latest fiscal quarter. This beat analysts’ estimates of about $33...
Source: MDDI - May 7, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Cardiovascular Source Type: news

Varian acquires Taiwanese distributor Cooperative CL Enterprises
Varian Medical (NYSE:VAR) said today it acquired Taiwanese radiotherapy equipment distributor Cooperative CL Enterprises for an undisclosed amount. The distribution company, based in Taipei, currently employs approximately 45 individuals and has represented and distributed Varian equipment for more than 40 years, the Palo Alto, Calif.-based company said. “With the acquisition of COOP, Varian will be able to work and collaborate more closely with our customers in Taiwan as well as providing more efficient and comprehensive services,” Varian Asia Pacific prez Kevin O’Reilly said in a pre...
Source: Mass Device - May 7, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Distribution Mergers & Acquisitions Varian Medical Systems Source Type: news

Dentsply Sirona shares down despite Street-beating Q1
Shares in Dentsply Sirona (NSDQ:XRAY) have fallen today despite the dental-focused medical device maker posting first quarter 2018 earnings that topped consensus on Wall Street. The York, Penn.-based company posted profits of $81.2 million, or $59.8 million per share, on sales of $956.1 million for the three months ended March 31, for bottom-line growth of 35.8% while sales grew 34.6% compared with the same period during the previous fiscal year. Adjusted to exclude one-time items, earnings per share were 45¢, just ahead of the 42¢ consensus on Wall Street where analysts expected to see sales of $940.8 milli...
Source: Mass Device - May 7, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat Dentsply Sirona Source Type: news

Insurers Post Obamacare Profits With Little Interest In Trump Plans
Health insurers coming off a solid first quarter of Obamacare profits aren't yet including the Trump administration's short-term policies or skimpier benefits into their financial outlooks. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 6, 2018 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Tags: NYSE:CNC NYSE:ANTM NYSE:CI NYSE:MOH Source Type: news

SeaSpine Holdings slashes losses with Street-beating Q1 results
SeaSpine Holdings (NSDQ:SPNE) yesterday slashed its first-quarter losses by more than 20% on the way to beating the consensus forecast on Wall Street, sending share prices up today in New York. Carlsbad, Calif.-based SeaSpine posted losses of -$7.1 million, or -50¢ per share, on sales of $33.2 million for the three months ended March 31, cutting its red ink by -21.9% on sales growth of 4.0% compared with Q1 2017. Analysts were looking for losses per share of -53¢ on sales of $32.7 million. “We are pleased with our first-quarter results, which reflect solid revenue growth in both our orthobiologics and ...
Source: Mass Device - May 4, 2018 Category: Medical Devices Authors: Brad Perriello Tags: MassDevice Earnings Roundup Orthopedics Wall Street Beat SeaSpine Source Type: news

Varex meets The Street with fiscal Q2 earnings
Varex Imaging (NSDQ:VREX) yesterday met the consensus forecast with its fiscal second-quarter results, powered by a 30% top-line surge, sending share prices up today. The Salt Lake City-basedX-ray imaging components maker posted profits of $12.2 million, or 32¢ per share, on sales of $201.2 million for the three months ended March 30, for a bottom-line slide of -18.7% compared with Q2 2017. Adjusted to exclude one-time items, earnings per share were 45¢, in-line with The Street, where analysts were looking for revenues of $187.3 million. “We had a strong quarter led by higher sales of our products for ...
Source: Mass Device - May 4, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Imaging MassDevice Earnings Roundup Wall Street Beat Varex Imaging Source Type: news

Endologix promotes COO to corner office, posts mixed Q1 results
Endologix (NSDQ:ELGX) promoted chief operating officer John Onopchenko to CEO just in time for him to take the lead on the company’s first-quarter financial results. Onopchenko served as the Irvine, Calif.-based company’s COO for the past seven months. He has spent 30 years in the medical device industry, including nearly a decade at Johnson & Johnson (NYSE:JNJ), where he led medical device investments and worldwide operations for the company’s advanced sterilization products unit. “Since joining the company as COO, I have been deeply involved in the operations of the organization, and...
Source: Mass Device - May 4, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: MassDevice Earnings Roundup Stent Grafts Vascular Wall Street Beat Endologix johnsonandjohnson Source Type: news

Insulet sales grow 22% in Q1
Insulet (NSDQ:PODD) topped estimates on Wall Street yesterday with its first-quarter results, topping analysts’ sales expectations by $1.9 million. The Billerica, Mass.-based company reeled in its losses, posting a net loss of -$6.6 million, or -11¢ per share, on sales of $123.6 million for the 3 months ended March 31, for bottom-line growth of 34.2% on sales growth of 21.5% compared with the same period last year. Get the full story at our sister site, Drug Delivery Business News. The post Insulet sales grow 22% in Q1 appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - May 4, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations MassDevice Earnings Roundup Pharmaceuticals Wall Street Beat Insulet Source Type: news

Integer to deal surgical, orthopedics assets to MedPlast for $600m
Integer Holdings (NYSE:ITGR) said yesterday that it plans to sell its advanced surgical and orthopedic assets to MedPlast for $600 million in a deal that will double MedPlast’s top line and bolster the balance sheet for Integer, which missed expectations with its first-quarter earnings. Proceeds from the all-cash deal, expected to close during the third quarter, are slated to be used to pay down debt, Integer president & CEO Joe Dziedzic said in prepared remarks. The deal does not include Frisco, Texas-based Integer’s portable medical line, the companies said. “After this divestiture and pay...
Source: Mass Device - May 4, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Contract Manufacturing MassDevice Earnings Roundup Mergers & Acquisitions Orthopedics Surgical Wall Street Beat integer MedPlast Source Type: news

Siemens Healthineers Fully on Track to Meet the Targets
Siemens Healthineers AG has posted good business figures in the first quarter following its successful initial public offering on March 16, 2018. Year-over-year revenue was up four percent at EUR 3.2 billion on a comparable basis. Despite continuing negative currency effects, the profit margin adjusted for non-recurring effects increased by 90 basis points to 17.4 percent, while adjusted profit was stable at EUR 560 million compared to the second quarter of 2017. (Source: eHealth News EU)
Source: eHealth News EU - May 4, 2018 Category: Information Technology Tags: Featured Siemens Business and Industry Source Type: news

Cardinal Health down on shrinking profits, EPS miss in Q3 earnings
Shares in Cardinal Health (NYSE:CAH) fell today after the medical device maker missed EPS expectations and posted shrinking sales in its fiscal year 2018 third quarter earnings release. The Dublin, Ohio-based company posted profits of $255 million, or 81¢ per share, on sales of $33.6 billion for the three months ended March 31, seeing the bottom-line shrink 33.1% while sales grew by 5.7% compared with the same period during the previous fiscal year. Adjusted to exclude one-time items, earnings per share were $1.39, just behind the $1.51 consensus on Wall Street, where analysts expected to see sales of $33.5 billi...
Source: Mass Device - May 3, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat Cardinal Health Source Type: news

Fresenius shares dip on Q1 EPS, sales miss
Shares in Fresenius Medical Care (NYSE:FMS; ETR:FRE) have fallen slightly today after the dialysis-focused medical group missed expectations on Wall Street and saw sales and profits shrink in their first quarter earnings report. The Bad Homburg vor der Höhe, Germany-based company posted profits of $292.3 million, or $1.09 per share, on sales of $4.8 billion for the three months ended March 31, seeing the bottom-line shrink by 2% while sales shrunk by 12.7% compared with the same period last year. After adjusting for one-time items, earnings per share were 54¢, just below the 67¢ consensus on Wall Street...
Source: Mass Device - May 3, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat Fresenius Source Type: news

Masimo raises outlook on Street-beating Q1 numbers
Masimo (NSDQ:MASI) yesterday raised its outlook for the rest of the year after posting first-quarter results that beat both sales and earnings forecasts, despite lower profits. Irvine, Calif.-based Masimo reported profits of $45.6 million, or 82¢ per share, on sales of $213.0 million for the three months ended March 31, for a bottom-line slide of -11.5% on sales growth of 8.3% compared with Q1 2017. Adjusted to exclude one-time items, earnings per share were 75¢, 6¢ ahead of the consensus forecast on Wall Street, where analysts were looking for revenues of $205.8 million. “We had another record qu...
Source: Mass Device - May 3, 2018 Category: Medical Devices Authors: Brad Perriello Tags: MassDevice Earnings Roundup Patient Monitoring Wall Street Beat Masimo Source Type: news

Abiomed shares rise on Street-beating Q4, FY2018 earnings
Shares in Abiomed (NSDQ:ABMD) are rising today after the medical device maker beat expectations on Wall Street and saw massive growth to its profits in its fourth quarter and full fiscal year 2018 earnings results. The Danvers, Mass.-based posted profits of $36.9 million, or 80¢ per share, on sales of $174.4 million for the three months ended March 31, seeing bottom-line growth of 147.3% while sales grew 39.9% compared to the same period during the previous year. Earnings per share for the fourth quarter were well ahead of the 64¢ consensus on Wall Street, where analysts expected to see sales of $164.3 milli...
Source: Mass Device - May 3, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat Abiomed Source Type: news